Latest News from: Vanderbilt University Medical Center

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 546

Article ID: 714599

Patients of Surgeons With Higher Reports of Unprofessional Behaviors Are More Likely to Suffer Complications

Vanderbilt University Medical Center

Patients of surgeons with higher numbers of reports from co-workers about unprofessional behavior are significantly more likely to experience complications during or after their operations, researchers from Vanderbilt University Medical Center (VUMC) reported today in JAMA Surgery.

Released:
19-Jun-2019 11:05 AM EDT

Social and Behavioral Sciences

Article ID: 714332

$10 Million Gift Bolsters Psychosis Research Efforts

Vanderbilt University Medical Center

Vanderbilt University Medical Center’s Department of Psychiatry and Behavioral Sciences has received a $10 million endowed gift to fund translational research, support clinical programs and create an endowed chair within the department.

Released:
13-Jun-2019 10:05 AM EDT

Article ID: 714147

Study Drug Delays Type 1 Diabetes in High Risk Children and Adults

Vanderbilt University Medical Center

A drug that targets the immune system can delay the onset of type 1 diabetes an average of two years in children and adults at high risk, according to findings from TrialNet’s Teplizumab (anti-CD3) Prevention Study published in the New England Journal of Medicine.

Released:
10-Jun-2019 9:45 AM EDT
Newswise: Immunotherapy Keeps 87-year-old Man on the Job

Article ID: 713849

Immunotherapy Keeps 87-year-old Man on the Job

Vanderbilt University Medical Center

Five-year survival data for pembrolizumab patients with advanced non-small cell lung cancer were presented June 1 at the 2019 ASCO Annual Meeting, May 31-June 4, in Chicago. The study results showed a marked improvement over 5-year survival rates in the pre-immunotherapy era, which averaged only 5.5%. Pembrolizumab increased the survival rate to 23.2% after five years in people with advanced non-small cell lung cancer who had not previously been treated with chemotherapy and to 15.5% in those who had been previously treated with chemotherapy. The KEYNOTE-001 is the longest follow-up study to date of people with advanced non-small cell lung cancer treated with pembrolizumab.

Released:
3-Jun-2019 2:05 PM EDT
  • Embargo expired:
    16-May-2019 2:00 AM EDT

Article ID: 712855

Brain network activity can improve in epilepsy patients after surgery

Vanderbilt University Medical Center

Successful epilepsy surgery can improve brain connectivity similar to patterns seen in people without epilepsy, according to a new study published in the journal Neurosurgery.

Released:
14-May-2019 2:05 PM EDT
Newswise: More Congenital Heart Patients Becoming Transplant Candidates

Article ID: 712626

More Congenital Heart Patients Becoming Transplant Candidates

Vanderbilt University Medical Center

Patients with a form of congenital heart disease — having only one ventricle (pumping chamber) — are now living longer lives due to the successful surgical and medical treatments they receive as children.

Released:
9-May-2019 10:05 AM EDT
Newswise: Technology Better Than Tape Measure for Identifying Lymphedema Risk

Article ID: 712505

Technology Better Than Tape Measure for Identifying Lymphedema Risk

Vanderbilt University Medical Center

Bioimpedance spectroscopy (BIS) is better than a tape measure for assessing a woman’s risk for developing lymphedema, painful swelling in the arm after breast cancer surgery.

Released:
7-May-2019 2:05 PM EDT
Newswise: Damaged Lungs Regenerated in Study
  • Embargo expired:
    7-May-2019 11:00 AM EDT

Article ID: 712392

Damaged Lungs Regenerated in Study

Vanderbilt University Medical Center

A new technique to rehabilitate lungs that are too damaged to be considered for transplant could benefit an increasing population of patients with end-stage lung disease.

Released:
6-May-2019 9:40 AM EDT
Newswise: VUMC, UCSF Win KidneyX Award for Home Dialysis Design

Article ID: 712351

VUMC, UCSF Win KidneyX Award for Home Dialysis Design

Vanderbilt University Medical Center

A roadmap to create an implantable dialysis system that would allow patients to treat kidney failure at home has won researchers from Vanderbilt University Medical Center (VUMC), UC San Francisco (UCSF), and Silicon Kidney one of 15 cash prizes in the inaugural KidneyX’s Redesign Dialysis Phase I competition.

Released:
3-May-2019 10:05 AM EDT
Newswise: New technology helps patients who require frequent X-rays

Article ID: 712249

New technology helps patients who require frequent X-rays

Vanderbilt University Medical Center

The EOS X-ray imaging system uses ultra-low radiation doses (up to 50 times lower depending on the scan type) to capture 2-D and 3-D images. The scan, complete in about eight to 15 seconds, obtains an image of the body in an upright, load-bearing position, which is more representative of the body’s natural function.

Released:
1-May-2019 4:05 PM EDT

Showing results

110 of 546

Chat now!